Investors & Media
Overview
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments.
Stock Information
Upcoming Events
February 25 - 27, 2020
April 8, 2020